Roche looking to sell or shut down California biologic drug plant | Reuters News Agency
DealsHealth

Roche looking to sell or shut down California biologic drug plant

Reuters has exclusively seen documents indicating Swiss drugmaker Roche Holding AG (ROG.S) plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029. 

Market Impact

Roche is under pressure to develop new treatments to offset the loss of billions in sales due to cheap biotech copies of its established cancer medicines Herceptin, Avastin and Rituxan.



Article Tags
Topics of Interest: DealsHealth
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Americas
Countries: SwitzerlandUnited States
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Significant National Story
workspace_6.1.23_roche
Sign up for email updates
Subscribe
Sign up for email updates